S-phase fraction of 155 soft tissue sarcomas: Correlation with clinical outcome

Cancer

Volumn 77, Issue 9, 1996, Pages 1815-1822

  Huuhtanen, Riikka L ^a   Blomqvist, Carl P ^a   Wiklund, Tom A ^a   Virolainen, Martti J ^a   Elomaa, A Inkeri ^a   Pan, Yi ^b   Tribukait, Bernhard ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

flow cytometry; ploidy; prognosis; S phase; soft tissue sarcoma; survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL PROLIFERATION; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIPLOIDY; EXTREMITIES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PLOIDIES; PROGNOSIS; S PHASE; SARCOMA; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; THORACIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0029978148     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960501)77:9<1815::AID-CNCR9>3.0.CO;2-A     Document Type: Article

References (36)

1. Alvegard TA, Berg NO, Ranstam J, Rydholm A, Rooser B. Prognosis in high-grade soft tissue sarcomas. The Scandinavian Sarcoma Group experience in a randomized adjuvant chemotherapy trial. Acta Orthop Scand 1989;60:517-21.
2. Collin C, Godbold J, Hajdu S, Brennan M. Localized extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol 1987;5:601-12.
3. Rooser B, Attewell R, Berg NO, Rydholm A. Survival in soft tissue sarcoma. Prognostic variables identified by multivariate analysis. Acta Orthop Scand 1987;58:516-22.
4. Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986;58:306-9.
5. Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984;53:530-41.
6. Alvegard TA, Berg NO. Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J Clin Oncol 1989;7:1845-51.
7. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
8. Heiden T, Wang N, Tribukait B. An improved Medley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry 1991;12: 614-21.
9. Stotter AT, A'Hern RP, Fisher C, Mott AF, Fallowfield ME, Westbury G. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer 1990;65:1119-29.
10. Ueda T, Aozasa K, Tsujimoto M, Hamada H, Hayashi H, Ono K, et al. Multivariate analysts for clinical prognostic factors in 163 patients with soft tissue sarcoma. Cancer 1988;62: 1444-50.
11. Enzinger FM, Weiss SW. General consideration in Enzinger FM, Weiss SW. Soft tissue tumors. 2nd edition. St. Louis: C V Mosby Co., 1988:10-11.
12. Agarwal V, Greenebaum E, Wersto R, Koss LG. DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome. Arch Pathol Lab Med 1991; 115:558-62.
13. Bauer HC, Kreicbergs A, Tribukait B. DNA content prognostic in soft tissue sarcoma. 102 patients followed for 1-10 years. Acta Orthop Scand 1991;62:187-94.
14. Malmstrom H, Schmidt H, Persson PG, Carstensen J, Nordenskjold B, Simonsen E. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators. Gynecol Oncol 1992;44:172-7.
15. Naggar A, Ayala AG, Abdul KF, McLemore D, Ballance WW, Garnsey L, et al. Synovial sarcoma. A DNA flow cytometric study. Cancer 1990;65:2295-300.
16. Tsushima K, Stanhope CR, Gaffey TA, Lieber MM. Uterine leiomyosarcomas and benign smooth muscle tumors: usefulness of nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc 1988;63:248-55.
17. Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival. Am J Surg Pathol 1993;17:35-44.
18. Naggar A, Garcia GM. Epithelioid sarcoma. Flow cytometric study of DNA content and regional DNA heterogeneity. Cancer 1992;69:1721-8.
19. Gustafson P, Willen H, Baldetorp B, Ferno M, Akerman M, Rydholm A. Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer 1992;70:114-9.
20. Gustafson P, Rydholm A, Willen H, Baldetorp B, Ferno M, Akerman M. Liposarcoma: a population-based epidemiologic and prognostic study of features of 43 patients, including tumor DNA content. Int J Cancer 1993;55:541-6.
21. Alvegard TA, Berg NO, Baldetorp B, Ferno M, Killander D, Ranstam J, et al. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J Clin Oncol 1990;8:538-47.
22. Wijnaendts LC, van der Linden JC, van Diest PJ, van Unnik AJ, Delemarre JF, Voute PA, et al. Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas. J Clin Pathol 1993;46:948-52.
23. Zehr RJ, Bauer TW, Marks KE, Weltevreden A. Ki-67 and grading of malignant fibrous histiocytomas. Cancer 1990; 66:1984-90.
24. Ueda T, Aozasa K, Tsujimoto M, Ohsawa M, Uchida A, Aoki Y, et al. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989;63:1607-11.
25. Drobnjak M, Latres E, Pollack D, Karpeh M, Dudas M, Woodruff JM, et al. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J Natl Cancer Inst 1994;86:549-54.
26. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, et al. Soft-tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37-42.
27. Zalupski MM, Maciorowski Z, Ryan JR, Ensley JF, Hussein ME, Sundareson AS, et al. DNA content parameters of paraffin-embedded soft tissue sarcomas: optimization of retrieval technique and comparison to fresh tissue. Cytometry 1993;14:327-33.
28. Hedley DW. Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 1989;10:229-41.
29. Kallioniemi OP, Visakorpi T, Holli K, Heikkinen A, Isola J, Koivula T. Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry 1991;12:413-21.
30. Zalupski MM, Ryan JR, Ensley JF, Maciorowski Z, Pietraszkiewicz H, Hussein ME, et al. Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasms. Cytometry 1993;14:922-30.
31. Fossa SD, Berner A, Waehre H, Heiden T, Juul ME, van den Ouden D, et al. DNA ploidy in cell nuclei from paraffin-embedded material - comparison of results from two laboratories. Cytometry 1992;13:395-403.
32. Joensuu H, Kallioniemi OP. Different opinions on classification of DNA histograms produced from paraffin-embedded tissue. Cytometry 1989;10:711-7.
33. Kallioniemi OP, Joensuu H, Klemi P, Koivula T. Inter-laboratory comparison of DNA flow cytometric results from paraffin-embedded breast carcinomas. Breast Cancer Res Treat 1990;17:59-61.
34. Woosley JT. Measuring cell proliferation. Arch Pathol Lab Med 1991;115:555-7.
35. Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuke WL. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry [see comments]. N Engl J Med 1989;320:627-33.
36. Yang JC, Rosenberg SA, Glatstein EJ, Antman KH. Sarcomas of Soft Tissue in DeVita T, Hellman S, Rosenberg S. Cancer. Principles and practice of oncology. Philadelphia: JB Lippincott Co., 1993:1442-3.